Skip to content

Effects of Spirulina consumption on patients with hypertension

Effects of food containing spirulina algae consumption on blood pressure, antropometric parameters, serum lipid profile and inflammation and oxidative stress indices on patients with hypertension

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200404046940N1
Enrollment
48
Registered
2020-06-07
Start date
2019-10-07
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Hypertension. Essential (primary) hypertension

Interventions

Intervention 1: Intervention group: The group receiving the food product containing spirulina algae would use the product containing 2 grams of Spirulina per day up to 2 months. The products were prod

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
24 Years to 65 Years

Inclusion criteria

Inclusion criteria: Systolic blood pressure 130 mm Hg or more Diastolic blood pressure 80 mm Hg or more Both of the above Between the age of 24 and 65 years

Exclusion criteria

Exclusion criteria: Suffering from cardiovascular, liver, kidney, inflammatory bowel disease, diabetes and thyroid disorders History of cardiac surgery Weight loss of more than 5% in the last 3 months Participate in other studies in the last 6 months Use any supplements or diets Pregnancy and lactation History of inflammation in the past two weeks (including infection, fracture, etc.)

Design outcomes

Primary

MeasureTime frame
Blood pressure. Timepoint: Measurement of blood pressure before and 60 days after the intervention. Method of measurement: Digital Arm Sphygmomanometer.;Serum lipid profile. Timepoint: Before and 60 days after the intervention. Method of measurement: By the means of Pars Azmoon Company kit and auto analyzer BT 1500.;Hs-CRP (high-sensitivity C-reactive protein). Timepoint: Before and 60 days after the intervention. Method of measurement: By Enzyme-linked immunosorbent assay (ELISA) kit.;Malondialdehyde. Timepoint: Before and 60 days after the intervention. Method of measurement: Thiobarbituric acid method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZohreh Ghaem Far

Shiraz University of Medical Sciences

zohreh.ghaemfar@gmail.com+98 76 3334 8693

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026